Clinical framing: Several days of reproducible, flu-like fatigue after ejaculation raises the possibility of a sexual-activity-associated syndrome, but this is a diagnosis of exclusion; assess it within a structured fatigue assessment while actively seeking alternative physical, sleep-related, medication-related, psychological, and sexual-health causes. NICE CKS
History: Clarify the exact temporal relationship to ejaculation, latency of onset, duration, consistency after intercourse/masturbation/nocturnal emission, associated symptoms (for example feverishness, myalgia, headache, cognitive symptoms, rhinitis, pelvic/genital pain, dysuria, mood change, or erectile/ejaculatory difficulty), severity, functional impact, and whether rest, sleep or reduced sexual activity changes symptoms. NICE CKS
Distinguish fatigue from sleepiness, as daytime sleepiness may indicate obstructive sleep apnoea or another sleep disorder; a symptom, activity, sexual-event, and sleep diary can help establish reproducibility and identify modifiable triggers. NICE CKS
Ask specifically about post-exertional malaise, unrefreshing or disturbed sleep, and cognitive difficulty, because an activity-linked fatigue pattern may indicate ME/CFS or another coexisting condition rather than an ejaculation-specific disorder. NICE CKS
Take a focused sexual and genitourinary history, including libido, erectile function, ejaculation pain or abnormality, prostatitis-type symptoms, STI risk, fertility concerns, relationship context, and the degree of avoidance or distress caused by the episodes. NICE CKS
Screen for depression, anxiety, trauma-related symptoms, psychosocial stressors, relationship difficulties, alcohol and recreational-drug use, and the effect on work, family, and sexual relationships. NICE CKS
Review all prescribed, over-the-counter, herbal, performance-enhancing, and recreational substances, including chronology relative to symptom onset; atomoxetine, for example, is associated with fatigue, lethargy, ejaculation disorder, erectile dysfunction, prostatitis and male genital pain. SmPC Atomoxetine
Examination and initial tests: Perform observations and a targeted general examination, including weight/nutritional assessment, cardiovascular, respiratory, abdominal, neurological, endocrine and mental-state examination, with genital, prostate, or pelvic examination guided by symptoms and consent. NICE CKS
Use targeted rather than indiscriminate investigations, guided by history and examination, to exclude common or potentially serious causes of fatigue and any sexual or urinary pathology suggested clinically. NICE CKS
Where there are urinary, pelvic, genital, systemic, or STI-risk symptoms, investigate appropriately for urinary infection, prostatitis, and sexually transmitted infection, and consider relevant examination and referral pathways. NICE CKS
Consider a baseline fatigue screen when clinically indicated, such as FBC, ferritin/iron studies, renal, liver and thyroid function, glucose/HbA1c, inflammatory markers and other tests directed by the history, examination or risk profile; avoid repeated untargeted testing after an appropriate negative assessment. NICE CKS
Pregnancy testing is relevant when applicable, and assessment should also consider chronic cardiac, respiratory, renal, hepatic, autoimmune/rheumatological and chronic-pain conditions that can cause or coexist with fatigue. NICE CKS
Red flags and escalation: Urgent same-day assessment is warranted for chest pain, syncope, acute neurological deficit, severe headache, significant breathlessness, sepsis features, acute testicular pain/swelling, priapism, or suicidal risk. NICE CKS Persistent constitutional symptoms, objective fever, weight loss, lymphadenopathy, focal neurological signs, abnormal examination findings, or significant laboratory abnormalities should prompt directed investigation and appropriate specialty referral. NICE CKS
Management: Give a clear explanation that fatigue after ejaculation can be distressing but that management should first address an identified cause, such as sleep disorder, depression/anxiety, medication adverse effects, endocrine/metabolic disease, infection, or genitourinary pathology. NICE CKS
Advise a short-term, patient-led strategy of avoiding or spacing the trigger, planning recovery time, maintaining sleep regularity, hydration, nutrition and graded day-to-day activity within tolerance, while the diagnostic assessment proceeds. NICE CKS
Review potentially contributory medicines with the prescriber rather than stopping them abruptly; where a suspected adverse drug reaction is identified, consider dose adjustment, switching, or specialist advice and report suspected reactions through the Yellow Card scheme when appropriate. SmPC Atomoxetine
If assessment is reassuring, symptoms are isolated, and there are no red flags, use planned watchful waiting with safety-netting and review rather than broad repeated testing, because untargeted testing in isolated fatigue has low diagnostic yield and can produce false-positive results and overdiagnosis. NICE CKS
Refer to urology for persistent or complex ejaculatory/genital symptoms, suspected structural genital/testicular abnormality, relevant trauma, or failure of appropriate primary-care management; consider endocrinology if hypogonadism or testosterone deficiency is suspected, and psychosexual/relationship or mental-health services where psychological, relationship, or significant mental-health factors predominate. NICE CKS
There is no directly relevant evidence in the supplied PubMed material for a specific pharmacological treatment of post-ejaculatory fatigue; therefore, avoid empiric syndrome-specific drug treatment and individualise care to the findings of the assessment. NICE CKS
Key References
- NICE CKS: Tiredness/fatigue in adults
- NICE CKS: Erectile dysfunction
- SmPC: Atomoxetine Glenmark 80 mg hard capsules
- SmPC: Atomoxetine Glenmark 100 mg hard capsules
- SmPC: Atomoxetine Glenmark 18 mg hard capsules
- SmPC: Atomoxetine Glenmark 40 mg hard capsules
- (Kontbay Çetin and Keskin Sarılar Z., 2025): Evaluation of Heavy Menstrual Bleeding in Adolescents
- (Unknown, 2019): Abstracts from the 39th Congress of the Société Internationale d'Urologie, Athens, Greece, October 17-20, 2019.
- (Unknown, 2024): EPOSTERS